Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study
By March, 2023, 54 countries, areas, and territories (hereafter CAT) in the WHO European Region had reported more than 2·2 million COVID-19-related deaths to the WHO Regional Office for Europe.
Article
Scientific Papers
News
Uncovering the Contrasts and Connections in PASC: Viral Load and Cytokine Signatures in Acute COVID-19 versus Post-Acute Sequelae of SARS-CoV-2 (PASC)
The recent global COVID-19 pandemic has had a profound and enduring impact, resulting in substantial loss of life.
Will individuals need an annual COVID-19 vaccination?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
Can vaccinated individuals still get COVID?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
Can COVID-19 vaccines be trusted when they have been developed so quickly?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
Is it dangerous to get an influenza and COVID-19 vaccine at the same time?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
Is COVID-19 worse than influenza?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
How can you tell the difference between RSV and other respiratory diseases, like COVID-19 or influenza?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December 2020 to March 2023: a retrospective surveillance study
Over nearly 2.5 years, most lives saved by COVID-19 vaccination were in older adults by first booster dose and during the Omicron period, reinforcing the importance of up-to-date vaccination among the most at-risk individuals.
Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain
The objective of this study is to estimate the burden of selected immunization-preventable infectious diseases in Spain.
Enough already: T cell inflammation and SARS-CoV-2 virus persist in Long Covid
It is estimated that 6% of American adults currently suffer from persistent symptoms that can linger for weeks to years after COVID-19 infection.
COVID-19 health information system assessments in eight European countries: identified gaps, best practices and recommendations
Global threats, such as the coronavirus disease 2019 (COVID-19) pandemic, have highlighted the critical importance of robust and well-functioning health information systems (HIS) in effectively addressing public health emergencies.
